retina; diabetic retinas; fibrovascular membranes; idiopathic epiretinal membranes; peripheral blood; plasma fraction; cellular fraction; aqueous humor
HRVECs; EA.hy.926; human coronary artery endothelial cells; human umbilical vein endothelial cells; HEK293T cells; human retinal endothelial cells; mouse retinal endothelial cells
other disease animal model
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); angiogenesis (promotes); inflammation (promotes); VEGF/VEGFR (promotes); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; Northern Blot; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; MTT; EdU Staining; Transwell Assay; Tube Formation Assay; In Vivo Animal Model; ELISA; ChIP / ChIP-seq; Bioinformatics Analysis
circHIPK3 is upregulated in fibrovascular membranes, plasma, and aqueous humor of diabetic patients and is suggested as a potential target to control diabetic proliferative retinopathy and diabetes mellitus-induced vascular complications.
circHIPK3 is a HIPK3-derived circRNA conserved in human and mouse and is upregulated in diabetic retinas, diabetic patient fibrovascular membranes, plasma, and aqueous humor. It promotes retinal endothelial proliferation, migration, tube formation, vascular leakage, inflammation, and retinal vascular dysfunction by acting as a cytoplasmic sponge for miR-30a-3p and increasing VEGFC, FZD4, and WNT2 expression. Silencing circHIPK3 alleviates diabetes mellitus-induced retinal vascular dysfunction in vivo, suggesting therapeutic relevance.
0.8626
Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
combined biological and clinical study